Dr. Malcolm G. Munro MD,FRCSC,FACOG
Los Angeles CA
Dr. Munro is a Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA, and Director of Gynecologic Services at Kaiser Permanente's Los Angeles Medical Center. Dr. Munro's clinical and research interests are oriented to minimally invasive approaches to gynecological disorders with particular interests in surgical education and training as well as the problem of abnormal uterine bleeding (AUB) including investigation, teaching and medical and procedural interventions. He was a founding Co-Chair of FIGO’s Menstrual Disorders Committee that was responsible for the design of the two FIGO systems for nomenclature and classification of causes of AUB in the reproductive years. He was also the study chair of STOP-DUB, a US federally-funded, multicenter randomized clinical trial comparing hysterectomy to endometrial ablation that, to date, is the largest of its kind, and is currently the Principal Investigator for the EMIG Manual Skills Validation Trial, a multi-institutional, multinational collaboration that includes CREOG and ACOG designed to create a high stakes examination suitable for training certification. He has published more than 120 papers, 26 chapters, and four books including Abnormal Uterine Bleeding, released by Cambridge University Press in 2010. A new two volume textbook on surgery of the female reproductive tract, edited with Professor Victor Gomel, will be released by Taylor and Francis in late 2018. Dr Munro is a member of the editorial boards of the Journal of Minimally Invasive Gynecology, the Journal of Endometriosis and Chronic Pelvic Pain, and the Journal of Midlife Women’s Health. He has served the American Association of Gynecologic Laparoscopists (AAGL) as a member of the Board of Trustees (2000-2002) and was the inaugural chair of the AAGL Practice Committee, charged with the development of evidence based practice guidelines related to minimally invasive approaches to gynecology. He lives in Tarzana, a Los Angeles suburb, with his wife where they have raised three, now grown children.
I have a relationship with a for-profit and/or a not-for-profit organization to disclose:
- Membership on advisory boards or speakers’ bureaus: Abbvie Inc, Aegea Medical, Bayer Women's Health, Boston Scientific, Channel Medical, Gynesonics Inc., Hologic Inc.
- Funded grants or clinical trials: Abbvie Inc.
- Patents on a drug, product or device: Gynesonics
- All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity: CrossBay Medical
I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).